Change in Board’s Composition
| Press Release |
Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1st, 2025, Rodolfo J. Savitzky will step down from his role as EUROAPI’s Independent Director and Chair of the Audit Committee, effective December 31, 2025.
The search for a new Independent Director has been initiated, and Rodolfo J. Savitzky’s successor is expected to be appointed before the end of the year.
“On behalf of the Board, I would like to express my sincere gratitude to Rodolfo for his valuable contributions to the work of the Board and the Audit Committee throughout his tenure as Director. His experience and knowledge of the CDMO industry have been instrumental in supporting the Board, and EUROAPI’s management during the past 3 years,” said Emmanuel Blin, EUROAPI’s Chairman.
“It has been an honor to serve as EUROAPI’s Director and Chair of the Audit Committee and to contribute to its transformation journey,” said Rodolfo J. Savitzky. “As I step down from this role, I do so with full confidence in the successful execution of the Focus-27 plan and in EUROAPI’s right to win as a leading player in the API industry.”
Financial agenda (all dates to be confirmed)
- 3 March 2026: FY 2025 Results
- 27 May 2026: 2026 AGM
- 28 July 2026: H1 2026 results
About EUROAPI
EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.
Taking action for health by enabling access to essential therapies inspires our 3,270 people every day. With strong research and development capabilities and five manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find out more at and follow us on .
| Media Relations contact: Laurence Bollack Tel.: +33 (0)6 81 86 80 19 | Investor Relations contacts: Sophie Palliez-Capian Tel.: +33 (0)6 87 89 33 51 Léa Massonneau Tel: +33 (0)7 60 32 29 50 |
Forward-Looking Statements
Certain information contained in this press release is forward looking and not historical data. These forward-looking statements are based on opinions, projections and current assumptions including, but not limited to, assumptions concerning the Group’s current and future strategy, financial and non-financial future results and the environment in which the Group operates, as well as events, operations, future services or product development and potential. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Forward looking statements and information do not constitute guarantees of future performances, and are subject to known or unknown risks, uncertainties and other factors, a large number of which are difficult to predict and generally outside the control of the Group, which could cause actual results, performances or achievements, or the results of the sector or other events, to differ materially from those described or suggested by these forward-looking statements. These risks and uncertainties include those that are indicated and detailed in Chapter 3 “Risk factors” of the Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers, AMF) on April 1, 2025. These forward-looking statements are given only as of the date of this press release and the Group expressly declines any obligation or commitment to publish updates or corrections of the forward-looking statements included in this press release in order to reflect any change affecting the forecasts or events, conditions or circumstances on which these forward-looking statements are based.
Attachment
